Neurochemical Research 1999-02-01

Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.

U Bierfreund, T Lemm, A Hoffmann, G Uhlhorn-Dierks, R A Childs, C T Yuen, T Feizi, K Sandhoff

Index: Neurochem. Res. 24(2) , 295-300, (1999)

Full Text: HTML

Abstract

The interaction between glycosphingolipids and recombinant human GM2-activator was studied in a microwell binding assay. A-series gangliosides like GM3, GM2 and GM1 were strongly bound by the recombinant human GM2 activator. A weak binding was observed to GD1b and sulfatide, while neutral glycolipids were not bound. Optimal binding occurred at pH 4.2 and was inhibited by increasing concentrations of citrate buffer and NaCl. In contrast with these in vitro results the recombinant human GM2-activator is able to restore the degradation of GA2 in fibroblasts from patients with the AB variant of GM2 gangliosidosis in vivo.

Related Compounds

  • Ganglioside GM2...

Related Articles:

Asialo GM-2 developed on the fatty streak of atherosclerotic aorta detected by a novel monoclonal antibody (ASH1a/256C).

1995-01-17

[Ann. N. Y. Acad. Sci. 748 , 277-81; discussion 281-2, (1995)]

Catabolism of asialo-GM2 in man and mouse. Specificity of human/mouse chimeric GM2 activator proteins.

1999-10-01

[J. Biol. Chem. 274(40) , 28612-8, (1999)]

Optimal conditions to radiolabel (3H or 14C) aminosugar-containing glycosphingolipids by de-N-acetylation and re-N-acetylation.

1995-06-09

[Biochim. Biophys. Acta 1244(2-3) , 418-22, (1995)]

Soluble fibronectin interaction with cell surface and extracellular matrix is mediated by carbohydrate-to-carbohydrate interaction.

2000-02-01

[Arch. Biochem. Biophys. 374(1) , 93-9, (2000)]

Enzymatic sulfation of gangliotriaosylceramide in human renal cancer cells.

1995-05-01

[J. Biochem. 117(5) , 987-92, (1995)]

More Articles...